CLINICAL_TRIALS
trial_result
· 2023-10-18
Clinical Trial Update: Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI [Phase 2]
Summary
Phase 2 trial evaluating inhaled prostacyclin with hyperpolarized xenon MRI for response assessment in pulmonary vascular disease has completed with results pos…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bastiaan Driehuys | Conditions: Pulmonary Vascular Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-10-18